Related Experiment Video
Updated: Aug 23, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Total family unit Helicobacter pylori eradication and pediatric re-infection rates
Stephen Farrell1, Irene Milliken, Gary M Doherty
1Department of Child Health, Institute of Clinical Science, Queen's University Belfast, UK. s.farrell@qub.ac.uk
Insights
Eradicating Helicobacter pylori from an entire family did not significantly reduce childhood re-infection rates. Treating only the infected child is as effective as treating the whole family for preventing H. pylori re-infection.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Family Medicine
Background:
- Helicobacter pylori re-infection is more common in children than adults.
- The family unit is implicated in primary childhood H. pylori infection.
- The role of family in pediatric H. pylori re-infection is unclear.
Purpose of the Study:
- To investigate if the family unit influences pediatric H. pylori re-infection.
- To determine if eradicating H. pylori from the entire family reduces childhood re-infection risk.
Main Methods:
- Fifty families with an H. pylori-infected child were recruited.
- All family members underwent 13C-urea breath tests.
- Families were randomized to either treat the entire family or only the index child.
Main Results:
- Long-term follow-up (mean 62.2 months) showed low re-infection rates in both groups.
- Re-infection occurred in three children in the 'index case treatment' group versus one in the 'family unit treatment' group.
- Re-infection rates were 2.4% per patient per year (index case treatment) and 0.7% per patient per year (family unit treatment), p = .31.
Conclusions:
- This is the first study to assess H. pylori eradication in the entire family unit for pediatric re-infection.
- The study reports the longest follow-up period for pediatric H. pylori re-infection.
- Family unit H. pylori eradication does not significantly reduce re-infection rates in children.
Background:
Re-infection with Helicobacter pylori is more common in children than adults, and it is generally accepted that the family unit plays a significant role in primary childhood infection. We investigated whether the family unit plays a significant role in pediatric re-infection and if eradication of H. pylori from the entire family reduces the risk of childhood re-infection.
Methods:
Fifty families, each with an H. pylori-infected pediatric index case (mean age 9.48 years), were recruited. A 13carbon urea breath test was performed on all family members in the same house as the index case. Each family unit was randomized into a 'family unit treatment' group (all infected family members treated) or an 'index case treatment' group (index case only treated).
Results:
At long-term follow-up (mean 62.2 months), there were three re-infected children in the 'index case treatment' group compared with one in the 'family unit treatment' group. The re-infection rate was 2.4% per patient per year in the 'index case treatment' group and 0.7% per patient per year in the 'family unit treatment' group (p = .31).
Conclusions:
This study is the first to evaluate the effect of total family unit H. pylori eradication on pediatric re-infection rates and reports the longest period of re-infection follow-up in children. In childhood, re-infection with H. pylori is not significantly reduced by family unit H. pylori eradication.
More Related Videos
06:40Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
04:56Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis
Published on: May 16, 2025
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.